ASH 2023: S1318 benefit for older patients with Ph+ ALL
Featured News
Long-term results show combination treatment that skips chemotherapy is effective for older patients with Ph+ ALL
Dec 8, 2023
Dec 6, 2023
Dec 1, 2023
Dec 1, 2023
Ten years on, Lung-MAP success demonstrates potential of public-private partnerships in clinical research
Nov 24, 2023
Nov 21, 2023
The Fall 2023 issue of the Lung-MAP Newsletter is now out!
Nov 17, 2023
Nov 15, 2023
RNA-based molecular subtypes modestly improved predictions for pathologic downstaging in muscle-invasive bladder cancer.